Bebo HealthXPAR:MLBBO 47 FCF Yield % is 0.00 as of Jul. 03, 2026. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,124 Retail - Cyclical companies, Bebo Health ranks worse than 88967.88% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Bebo Health's FCF Yield % or its related term are showing as below:
XPAR:MLBBO's FCF Yield % is not ranked *
in the Retail - Cyclical industry.
Industry Median: 4.19 * Ranked among companies with meaningful FCF Yield % only.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bebo Health FCF Yield % Related Terms
Bebo Health FCF Yield % Historical Data
* Premium members only.
The historical data trend for Bebo Health's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: FCF Yield % Comparison
For the Specialty Retail subindustry, Bebo Health's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health FCF Yield % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Bebo Health's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health (XPAR:MLBBO) has a FCF Yield % of 0.00 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bebo Health and its competitors. According to the industry distribution chart, Bebo Health ranks #999999 out of 1124 companies in the Retail - Cyclical industry.
Is Bebo Health's FCF Yield % too high?
Bebo Health's current FCF Yield % is 0.00. Based on the distribution chart, Bebo Health ranks #999999 out of 1124 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's FCF Yield % compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #999999 out of 1124 companies for FCF Yield %. This places Bebo Health in the lower half of its industry. The industry median FCF Yield % is 4.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Retail - Cyclical company?
The median FCF Yield % among Retail - Cyclical companies is 4.19, based on 1,124 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median FCF Yield % is 4.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current FCF Yield % is 0.00. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current FCF Yield % is 0.00 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
FCF Yield %: 0.00
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 